NCT06514300View on ClinicalTrials.gov

Investigating Myosteatosis in Steatotic Liver Diseases

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

August 31, 2024

Study Completion Date

August 31, 2024

Conditions
Alcohol-related Liver DiseaseMetabolic Dysfunction Associated Steatotic Liver DiseaseSteatotic Liver Disease of Mixed Origin (MetALD)Steatotic Liver DiseasesMyosteatosisMagnetic Resonance ImagingMagnetic Resonance SpectroscopyLiver Histology
Trial Locations (1)

1200

Cliniques universitaires Saint-Luc, Brussels

Sponsors

Collaborators (1)

Concerted Research Action
All Listed Sponsors
collaborator

Fonds National de la Recherche Scientifique

OTHER

collaborator

Concerted Research Action

UNKNOWN

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER

NCT06514300 - Investigating Myosteatosis in Steatotic Liver Diseases | Biotech Hunter | Biotech Hunter